Abstract:Alzheimer's disease (AD) is characterized by regional reductions in fluorodeoxyglucose positron emission tomography (PET) measurements of the cerebral metabolic rate for glucose (CMRgl), which are correlated with clinical severity, progressive and apparent before the onset of dementia or mild cognitive impairment (MCI). We have been using statistical parametric mapping (SPM) to analyze PET data from probable AD patients, amnestic MCI (aMCI) patients and normal controls (NC) from the AD Neuroimaging Initiative (ADNI). Our objective was to characterize patterns of cerebral hypometabolism in probable AD and aMCI, and correlate lower Mini-Mental State Examination (MMSE) scores with lower regional CMRgl in both the overall cohort of probable AD, aMCI and NC subjects and the probable AD group. Baseline PET images from 298 subjects, including 74 probable AD (age 70±10, MMSE 23.5±2.2), 142 aMCI (age 67±12, MMSE 27.1±1.7) and 82 NC (69±10 years old, MMSE 28.9±1.1), were analyzed on a voxel-by-voxel basis using SPM5. ANOVA with pair-wise comparisons contrasted regional CMRgl in the three subject groups. Linear regression correlated lower MMSE scores with lower CMRgl in the overall cohort and probable AD group. Compared to NC, the probable AD and aMCI groups each had lower CMRgl bilaterally in previously characterized posterior cingulate, precuneus, and parietotemporal regions (P<0.05 corrected for multiple comparisons), and occipital cortex, hippocampus, parahippocampal gyrus and fusiform gyrus (uncorrected P<0.005). Compared to NC, the probable AD group had lower CMRgl in frontal regions (corrected P<0.05). In the overall cohort, lower MMSE scores were correlated with lower CMRgl in the posterior cingulate, precuneus, parietotemporal and frontal regions (P<0.05, corrected for multiple comparisons). In the probable AD group, lower MMSE scores were correlated with lower CMRgl in left frontal and temporal regions (uncorrected P<0.001). Findings from this large multi-center study confirm the previously characterized pattern of regional hypometabolism in AD and aMCI and implicate additional brain regions. Furthermore, they confirm the previously characterized correlation between severity of clinical impairment in a combined group of patients and controls, but suggest strongest correlations between clinical severity of frontal and temporal regions by the time AD patients satisfy criteria for dementia.

IC-P2-086: the Pattern of Cerebral Hypometablism in Amnestic Mild Cognitive Impairment and Its Relationship to Subsequent Conversion to Probable Alzheimer's Disease: Preliminary Findings from the Alzheimer's Disease Neuroimaging Initiative

IC‐P1‐036: Categorical and Correlational Analyses of Baseline Fluorodeoxyglucose Positron Emission Tomography Images from the Alzheimer's Disease Neuroimaging Initiative

P1‐312: Differentiating Amnestic Mild Cognitive Impairment Converting to Probable Alzheimer's Disease from Stable Amnestic Mild Cognitive Impairment Using FDG‐PET and an Alzheimer's Disease‐related Hypometabolism Overlap Index

IC‐P2‐074: Differentiating Amnestic MCI Converting to Probable AD from Stable Amnestic MCI Using FDG‐PET and an AD‐related Hypometabolism Overlap Index

Topographic extent of cerebral hypometabolism predicts time of conversion from aMCI to Alzheimer's disease: Data from the Alzheimer's Disease Neuroimaging Initiative

P-024: the Pattern and Severity of FDG Pet Abnormalities in Alzheimer’s Disease and Amnestic Mild Cognitive Impairment: Preliminary Findings from the Alzheimer’s Disease Neuroimaging Initiative

P1-338: the Consistency of Hypometabolic Brain Voxels in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients from the Alzheimer's Disease Neuroimaging Initiative

Decreased Bilateral FDG-PET Uptake and Inter-Hemispheric Connectivity in Multi-Domain Amnestic Mild Cognitive Impairment Patients: A Preliminary Study

Non-Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism

Retrosplenial hypometabolism precedes the conversion from mild cognitive impairment to Alzheimer's disease

DT‐01–06: Baseline FDG‐PET and Volumetric MRI Predicts Alzheimer's Disease Conversion from Mild Cognitive Impairment: an ADNI Study

Categorical and Correlational Analyses of Baseline Fluorodeoxyglucose Positron Emission Tomography Images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

Correlating Cerebral Hypometabolism with Future Memory Decline in Subsequent Converters to Amnestic Pre-Mild Cognitive Impairment

Assessing the Reliability to Detect Cerebral Hypometabolism in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment.

Twelve-month Metabolic Declines in Probable Alzheimer's Disease and Amnestic Mild Cognitive Impairment Assessed Using an Empirically Pre-Defined Statistical Region-of-interest: Findings from the Alzheimer's Disease Neuroimaging Initiative

The Pattern of Cerebral Hypometabolism and Its Association with Clinical Ratings in Cognitively Normal Older Adults with and Without Significant Fibrillar Amyloid Burden: Findings from the Alzheimer's Disease Neuroimaging Initiative

A PET Study of Discrimination of Cerebral Glucose Metabolism in Alzheimer's Disease and Mild Cognitive Impairment

Summary Metrics to Assess Alzheimer Disease–Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison

P1‐325: Predicting Progression to Mild Cognitive Impairment in Cognitively Unimpaired Individuals Using Neuroimaging Biomarkers

Alteration patterns of brain glucose metabolism: comparisons of healthy controls, subjective memory impairment and mild cognitive impairment

O1-04-05: Six-month Cerebral Metabolic Declines in Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Elderly Normal Control Groups: Preliminary Findings from the Alzheimer's Disease Neuroimaging Initiative